Healthcare - Biotechnology - NASDAQ - AU
$ 0.2911
-8.11 %
$ 5.68 M
Market Cap
-0.16
P/E
INCOME STATEMENT
0
REVENUE
-17.9 B
OPERATING INCOME
-15.5 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Bionomics Limited
| Revenue | 0 |
| Cost Of Revenue | 434 K |
| Gross Profit | -434 K |
| Operating Expenses | 17.9 B |
| Operating Income | -17.9 B |
| Other Expenses | -17.9 B |
| Net Income | -15.5 M |
Income Statement
Millions
| Jun-2024 | Jun-2023 | Jun-2022 | Jun-2021 | Jun-2020 | Jun-2019 | Jun-2018 | Jun-2017 | Jun-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 0 | 20 K | 0.3 | 0 | 50 K | 3.8 | 8.8 | 20.8 | 14.3 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 0.4 | 13.1 | 11.0 | 4.3 | 4.0 | 8.5 | 18.7 | 18.6 | 18.5 |
| Gross Profit | (0.4) | (12.6) | (6.9) | (3.6) | (2.0) | (3.3) | (9.9) | 2.2 | (4.1) |
| OPERATING INCOME | |||||||||
| Operating Expenses | 17 892.4 | 32.0 | 21.6 | 11.9 | 9.1 | 19.2 | 8.4 | 6.4 | 8.3 |
| Selling, General and Administrative Expenses | 8 474.6 | 8.9 | 7.7 | 5.7 | 4.8 | 9.3 | 7.9 | 6.4 | 7.9 |
| Research and Development Expenses | 9 417.8 | 19.6 | 16.0 | 5.8 | 5.8 | 9.0 | 18.7 | 18.6 | 18.5 |
| Operating Income | (17 892.4) | (32.0) | (21.3) | (11.9) | (9.0) | (15.4) | (17.8) | (4.2) | (12.0) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 0 | 20 K | 30 K | 1.2 | 1.8 | 2.4 | 1.5 | 1.4 | 1.4 |
| Total Other Income | 17 882.1 | (3.0) | (3.0) | 1.0 | 4.9 | 7.9 | (1.6) | (0.6) | (0.9) |
| Pre-Tax Income | (10.3) | (32.0) | (21.9) | (8.9) | (6.0) | (9.9) | (19.4) | (4.8) | (12.9) |
| NET INCOME | |||||||||
| Tax Provision | (87.3) | (0.2) | (0.2) | (0.2) | (0.2) | (0.2) | 0.9 | 0.4 | 0.5 |
| Net Income | (15 492.2) | (31.9) | (21.8) | (8.7) | (7.1) | (9.7) | (18.6) | (5.2) | (12.4) |
| EPS | 1.02 | 0.0217 | 0.0161 | 0.0112 | 0.0131 | 0.0186 | 0.0693 | 0.0194 | 0.0487 |